Recombinant UCHL1 anticorps (full length)
Aperçu rapide pour Recombinant UCHL1 anticorps (full length) (ABIN7879279)
Antigène
Voir toutes UCHL1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- full length
-
Fonction
- PGP9.5 Antibody / UchL1 (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogène
- Recombinant full-length human protein was used as the immunogen for the PGP9.5 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the PGP9.5 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the PGP9.5 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))
-
Autre désignation
- PGP9.5
-
Sujet
- This mAb reacts with a protein of 20-30 kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinson's disease.
-
UniProt
- P09936
-
Pathways
- Feeding Behaviour
Antigène
-